Browsing by Subject "Hydroxyurea adherence"
Now showing items 1-1 of 1
-
Hydroxyurea adherence and associated factors among children aged 12-59 months attending the Mulago hospital sickle cellclinic, Kampala, Uganda
(Makerere University, 2022-11-24)Background: In 2014, hydroxyurea (HU) treatment was approved for use for children with sickle cell anaemia (SCA) in Uganda. Currently, HU is prescribed for children with SCA attending Mulago Hospital Sickle Cell Clinic ...